Adamax: What It Is and What It Does

What Adamax is

Adamax belongs to the NAP / davunetide family — small peptides studied in brain science. It is supplied as an analytical-grade reference material for laboratory research.

Where it comes from

Adamax is studied as a member of the NAP / davunetide family. NAP is a short eight-amino-acid fragment (the sequence NAPVSIPQ) drawn from a larger human protein called activity-dependent neuroprotective protein, or ADNP — a protein brain researchers found is essential for normal brain development. In the late 1990s and 2000s, investigators isolated this small stretch and reported that it carried much of the parent protein's nerve-protecting activity in the lab, which is what made such a tiny peptide an attractive research tool. In drug development the same peptide has also been called davunetide (AL-108).

What it does — in plain terms

This family of peptides is studied for protecting nerve cells. In animal and some human studies, NAP/davunetide has been examined for keeping brain cells stable — including work on 'tau,' a protein that tangles up inside cells in certain brain disorders. So the research centers on neuroprotection: whether it can help nerve cells hold together under stress, along with effects on learning and memory in study models.

How it works

The clearest way to picture the NAP/davunetide family is as internal scaffolding support for nerve cells. Every neuron is held up and served by microtubules — tiny structural rails that also act as the cell's transport network, carrying cargo along the length of long, fragile nerve fibers. Across cell and animal studies, NAP appears to work mainly by helping keep these microtubules stable, which is thought to be the foundation of the neuroprotection researchers describe.

That scaffolding role connects directly to tau, the protein this family is best known for. Tau normally clings to microtubules and helps hold them together; in several brain disorders it becomes chemically over-modified ('hyperphosphorylated'), lets go, and clumps into the tangles seen in diseased tissue. In these models NAP has been examined for pushing that balance back the other way — reducing tau hyperphosphorylation so the scaffolding stays intact.

Beyond tau, the broader literature frames NAP/davunetide as generally protective of nerve-cell structure and function under stress. It is important to stay clear-eyed here: most of this mechanism work comes from cell and animal models, and the human data are limited and mixed, so these are research findings about how the peptide behaves in the lab rather than demonstrated benefits in people.

What the research shows

Adamax sits in an interesting spot: the preclinical neuroprotection literature for its NAP/davunetide family is genuinely substantial, yet the limited human testing done so far has generally not translated into clear clinical benefit. It is worth holding both of those facts together. With that context, here is what some of the key published work in this family actually reports.

• Pharmacology Research & Perspectives, 2014 — reported that intranasal NAP (davunetide) lowered tau hyperphosphorylation and improved behavioral deficits in an animal model.
• Current Pharmaceutical Design, 2011 — reviewed NAP (davunetide) as an agent providing both functional and structural neuroprotection of nerve cells.
• Schizophrenia Research, 2012 — evaluated davunetide (AL-108) on cognition and functional capacity in people with schizophrenia — one of the few human trials of this family, and one whose cognitive benefits were modest.

What Adamax is studied for

Neuroprotection and microtubule stability. The most-studied angle. In cell and animal models NAP/davunetide is examined as a microtubule stabilizer that helps nerve cells hold their structure and internal transport together under stress.

Tau and tauopathy models. Because the family influences the microtubule-tau balance, researchers study it in models of disorders where tau becomes hyperphosphorylated and forms tangles, asking whether it can blunt that process.

Learning and memory. Behavioral animal studies pair the neuroprotection work with tests of learning and memory, asking whether protecting nerve-cell structure carries through to cognitive performance in the model.

Human cognition trials. The peptide (as davunetide/AL-108) has also reached human testing in conditions such as schizophrenia, though the clinical cognitive benefits reported so far have been limited — an important caveat when reading the preclinical results.

Storage & handling

As a lyophilized (freeze-dried) powder, Adamax reference material is most stable kept cold and dark — refrigerated for short periods, or frozen for longer storage. Once reconstituted with bacteriostatic water it should be held refrigerated at roughly 2-8 °C, shielded from light, and protected from repeated freeze-thaw cycles, which are hard on small peptides. See the reconstitution reference below for the concentration math.

Reconstitution reference

Standard laboratory reconstitution volumes for Adamax, from the VNG Reconstitution Sheet. See the full reconstitution guide for the method and concentration math.